It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Secreted isoform of endoplasmic reticulum membrane complex subunit 10 (scEMC10) is a poorly characterized secreted protein of largely unknown physiological function. Here we demonstrate that scEMC10 is upregulated in people with obesity and is positively associated with insulin resistance. Consistent with a causal role for scEMC10 in obesity, Emc10-/- mice are resistant to diet-induced obesity due to an increase in energy expenditure, while scEMC10 overexpression decreases energy expenditure, thus promoting obesity in mouse. Furthermore, neutralization of circulating scEMC10 using a monoclonal antibody reduces body weight and enhances insulin sensitivity in obese mice. Mechanistically, we provide evidence that scEMC10 can be transported into cells where it binds to the catalytic subunit of PKA and inhibits its stimulatory action on CREB while ablation of EMC10 promotes thermogenesis in adipocytes via activation of the PKA signalling pathway and its downstream targets. Taken together, our data identify scEMC10 as a circulating inhibitor of thermogenesis and a potential therapeutic target for obesity and its cardiometabolic complications.
Secreted isoform of endoplasmic reticulum membrane complex subunit 10 (scEMC10) is a secreted protein of incompletely understood physiological function. Here the authors show that scEMC10 is upregulated in people with obesity, and that that genetic EMC10 deletion or antibody-based neutralization of EMC10 prevents diet-induced obesity in mice.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 Fudan University, Department of Endocrinology, Huashan Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
2 Fudan University, Department of Endocrinology, Huashan Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); University of Illinois at Chicago, Department of Physiology & Biophysics, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319); University of Illinois at Chicago, Department of Ophthalmology and Visual Sciences, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319)
3 University of Illinois at Chicago, Department of Physiology & Biophysics, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319); Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
4 Chinese Academy of Sciences, State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309); University of Chinese Academy of Sciences, Beijing, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419)
5 University of Illinois at Chicago, Department of Physiology & Biophysics, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319); University of Illinois at Chicago, Department of Ophthalmology and Visual Sciences, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319)
6 University of Illinois at Chicago, Department of Physiology & Biophysics, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319)
7 University of Illinois at Chicago, Department of Physiology & Biophysics, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319); Shanghai Jiao Tong University, Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)
8 Harvard Medical School, Research Division, Joslin Diabetes Center, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Harvard Medical School, Department of Transplant Surgery, Mass General Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
9 University of Illinois at Chicago, Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319)
10 Harvard Medical School, Research Division, Joslin Diabetes Center, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
11 Tianjin Medical University, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228)
12 Fudan University, Department of Urology, Huashan Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
13 Chinese Academy of Sciences, State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309); University of Chinese Academy of Sciences, Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, Hangzhou, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419)
14 University of Leipzig, Department of Medicine, Leipzig, Germany (GRID:grid.9647.c) (ISNI:0000 0004 7669 9786)